Theseus Pharmaceuticals, Inc.
THRX · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14 | -$15 | -$15 | -$14 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | -$2 | -$1 | $0 | $0 |
| Stock-Based Comp. | $4 | $4 | $3 | $2 |
| Change in WC | $0 | $2 | -$6 | $2 |
| Other Non-Cash | $0 | $0 | -$1 | -$0 |
| Operating Cash Flow | -$11 | -$10 | -$19 | -$10 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | $0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $167 |
| Inv. Purchases | -$10 | -$83 | -$57 | -$36 |
| Inv. Sales/Matur. | $20 | $31 | $41 | $25 |
| Other Inv. Act. | $0 | -$0 | -$0 | -$167 |
| Investing Cash Flow | $10 | -$52 | -$16 | -$11 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $49 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $49 | $0 |
| Financing Cash Flow | $0 | $0 | $49 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1 | -$62 | $15 | -$21 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $48 | $110 | $95 | $116 |
| End Cash | $47 | $48 | $110 | $95 |
| Free Cash Flow | -$11 | -$10 | -$19 | -$10 |